Are you looking for alternatives or a second opinion whether or not to undergo a prostate biopsy?

Standard diagnostic tests are best practice for finding prostate cancer but have their pitfalls. If you are concerned about prostate cancer because of an elevated PSA or are feeling insecure about a previous negative prostate biopsy, a biomarker test can be an option before undergoing a prostate biopsy.

However, as any test, biomarker tests also do not give you a 100% guarantee, meaning that there is a risk that the test is negative but that you do have prostate cancer. For some biomarker tests this risk is very small.

Explore your options below!

Dr. Inge van Oort
How sure do you want to be that a negative test result is truly negative (ruling out the presence of aggressive prostate cancer)?
  • at least 95%
  • at least 98%
  • 100%
95%
The new generation biomarker tests (e.g. 4K score and SelectMDx) have a higher certainty for ruling out aggressive prostate cancer (when the test is negative) than the old generation biomarker tests (e.g. PCA3, phi) and magnetic resonance imaging (MRI). The biomarker test SelectMDx for prostate cancer can rule out aggressive disease with 98% certainty.
98%
The new generation biomarker tests have a high certainty for ruling out aggressive prostate cancer. The biomarker test SelectMDx can rule out aggressive disease with 98% certainty.
100%
No test can give you a 100% guarantee for ruling out aggressive prostate cancer. But one of the new generation biomarker tests, SelectMDx, comes very close (98% certainty of no aggressive prostate cancer when the test is negative).

Your question about biomarkers can get an answer

Each individual has his own story and is unique. If you haven't found what you were looking for, and want guidance on your personal situation, an international group of experts in prostate cancer diagnosis is willing to give advice.
 

Ask your question

Editorial Board

Prof. David Crawford
Prof. E. David Crawford
University of Colorado, Denver, CO, USA
Prof. Alexandre de la Taille
Prof. Alexandre de la Taille
CHU Mondor, Assistance Publique des Hopitaux de Paris, Créteil, France
Dr. Giorgio Gandaglia
Dr. Giorgio Gandaglia
Department of Urology, San Raffaele Hospital, Milan, Italy
Prof. Christian Stief
Prof. Christian Stief
Ludwig-Maximilians-University, Munich, Germany
Dr. Inge van Oort
Dr. Inge van Oort
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands